BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 31456297)

  • 1. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
    Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T
    Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.
    Nalagatla N; Falloon K; Tran G; Borren NZ; Avalos D; Luther J; Colizzo F; Garber J; Khalili H; Melia J; Bohm M; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):502-509.e1. PubMed ID: 29944926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of accelerated and standard infliximab induction regimens in acute severe ulcerative colitis using propensity score analysis: a retrospective multicenter study in China.
    Liu X; Li H; Tian F; Xie Y; Zhang X; Zhi M; Zhang M; Song X; Guo H; Li X; Liang J; Shen J; Li Y
    Gastroenterol Rep (Oxf); 2024; 12():goae051. PubMed ID: 38855349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
    García MJ; Riestra S; Amiot A; Julsgaard M; García de la Filia I; Calafat M; Aguas M; de la Peña L; Roig C; Caballol B; Casanova MJ; Farkas K; Boysen T; Bujanda L; Cuarán C; Dobru D; Fousekis F; Gargallo-Puyuelo CJ; Savarino E; Calvet X; Huguet JM; Kupcinskas L; López-Cardona J; Raine T; van Oostrom J; Gisbert JP; Chaparro M
    Aliment Pharmacol Ther; 2024 May; 59(10):1248-1259. PubMed ID: 38445785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults.
    Subhaharan D; Ramaswamy PK; Willmann L; Moattar H; Bhullar M; Ishaq N; Dorrington A; Shukla D; McIvor C; Edwards J; Mohsen W
    World J Gastroenterol; 2023 Apr; 29(16):2469-2478. PubMed ID: 37179589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
    Battat R; Hemperly A; Truong S; Whitmire N; Boland BS; Dulai PS; Holmer AK; Nguyen NH; Singh S; Vande Casteele N; Sandborn WJ
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):511-518.e6. PubMed ID: 32348905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort.
    Ovesen PD; Attauabi M; Ilvemark JFKF; Wewer MD; Warren DJ; Burisch J; Klaasen RA; Bolstad N; Steenholdt C; Seidelin JB
    BMJ Open Gastroenterol; 2024 May; 11(1):. PubMed ID: 38719549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis.
    Gilmore R; Tan WL; Fernandes R; An YK; Begun J
    J Crohns Colitis; 2023 Dec; 17(12):2033-2036. PubMed ID: 37422724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Tacrolimus and Infliximab in Hospitalized Patients With Ulcerative Colitis.
    Takahashi T; Shiga H; Tarasawa K; Shimoyama Y; Naito T; Moroi R; Kuroha M; Kakuta Y; Fushimi K; Fujimori K; Kinouchi Y; Masamune A
    Clin Transl Gastroenterol; 2024 Jan; 15(1):e00642. PubMed ID: 37753937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Inpatient Infliximab Rescue Therapy for Acute Crohn's Disease Flares.
    Whitlock AE; Arndt KR; Zakopoulos I; Wong DJ; Kaul S; Feuerstein J; Crowell KT; Messaris E
    Am Surg; 2024 Jun; 90(6):1591-1598. PubMed ID: 38597300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining management strategies for acute severe ulcerative colitis using predictive models: a simulation-modeling study.
    Con D; De Cruz P
    Intest Res; 2024 May; ():. PubMed ID: 38712360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria.
    Naganuma M; Nakamura N; Kunisaki R; Matsuoka K; Yamamoto S; Kawamoto A; Saito D; Kobayashi T; Nanki K; Narimatsu K; Shiga H; Esaki M; Yoshioka S; Kato S; Saruta M; Tanaka S; Yasutomi E; Yokoyama K; Moriya K; Tsuzuki Y; Ooi M; Fujiya M; Nakazawa A; Takagi T; Omori T; Tahara T; Hisamatsu T;
    J Gastroenterol; 2024 Apr; 59(4):302-314. PubMed ID: 38277006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the care of adults hospitalized for active ulcerative colitis.
    Pola S; Patel D; Ramamoorthy S; McLemore E; Fahmy M; Rivera-Nieves J; Chang JT; Evans E; Docherty M; Talamini M; Sandborn WJ
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1315-1325.e4. PubMed ID: 22835577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab: the evidence for its place in therapy in ulcerative colitis.
    Van Assche G; Vermeire S; Rutgeerts P
    Core Evid; 2008 Feb; 2(3):151-61. PubMed ID: 21221182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series.
    Harvey C; Nahar KJ; McKeown J; Lo SN; Farag S; Yousaf N; Young K; Tas L; Meerveld-Eggink A; Blank C; Thomas A; McQuade J; Schilling B; Johnson DB; Huertas RM; Arance A; Lee J; Zimmer L; Long GV; Carlino MS; Wang Y; Menzies AM
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38296594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting.
    Clinton J; Motwani KK; Schwartz S; McCarthy P; Axelrad JE; Cross RK; George L
    Dig Dis Sci; 2024 Apr; 69(4):1105-1109. PubMed ID: 38418683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of acute severe ulcerative colitis.
    Kedia S; Ahuja V; Tandon R
    World J Gastrointest Pathophysiol; 2014 Nov; 5(4):579-88. PubMed ID: 25401001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis.
    Han YD; Al Bandar MH; Dulskas A; Cho MS; Hur H; Min BS; Lee KY; Kim NK
    BMC Surg; 2017 Mar; 17(1):28. PubMed ID: 28327112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous albumin infusion does not augment the response rate to a combination of exclusive enteral nutrition and intravenous steroids in acute severe ulcerative colitis: a randomized controlled trial.
    Mundhra SK; Madan D; Golla R; Sahu P; Vuyyuru SK; Kante B; Kumar P; Matthew D; Prasad S; Vaishnav M; Verma M; Virmani S; Bajaj A; Markandey M; Kumar Ranjan M; Arora U; Kumar Singh M; Makharia GK; Ahuja V; Kedia S
    J Crohns Colitis; 2024 Jun; ():. PubMed ID: 38881153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-hospitalization Short Versus Long Steroid Taper Strategies in Patients With Acute Severe Ulcerative Colitis: A Comparison of Clinical Outcomes.
    Alomari M; Chadalavada P; Afraz S; AlGhadir-AlKhalaileh M; Suarez ZK; Swartz A; Rashid M; Khazaaleh S; Cohen BL; Ur Rahman A; Alomari M
    Crohns Colitis 360; 2024 Apr; 6(2):otae025. PubMed ID: 38711857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.